X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
index medicus (106) 106
male (92) 92
infectious diseases (91) 91
female (89) 89
adult (84) 84
hiv infections - drug therapy (76) 76
hiv (73) 73
middle aged (71) 71
immunology (57) 57
microbiology (41) 41
virology (40) 40
antiretroviral therapy (39) 39
human immunodeficiency virus--hiv (39) 39
anti-hiv agents - therapeutic use (37) 37
hiv infections - virology (37) 37
antiretroviral drugs (35) 35
pharmacology & pharmacy (35) 35
drug therapy, combination (29) 29
aids (28) 28
drug therapy (28) 28
aged (27) 27
aids/hiv (27) 27
hiv infection (27) 27
italy (24) 24
treatment outcome (24) 24
hiv infections - immunology (23) 23
acquired immune deficiency syndrome--aids (22) 22
antiviral agents (22) 22
care and treatment (22) 22
cd4 lymphocyte count (22) 22
hiv-1 - drug effects (21) 21
infection (21) 21
research (21) 21
therapy (21) 21
health aspects (20) 20
risk factors (20) 20
anti-hiv agents - administration & dosage (19) 19
antiretroviral therapy, highly active (19) 19
italy - epidemiology (19) 19
patients (19) 19
ritonavir (19) 19
genotype (18) 18
pharmacokinetics (18) 18
analysis (17) 17
highly active antiretroviral therapy (17) 17
hiv infections - complications (17) 17
hiv-1 - genetics (17) 17
research article (17) 17
prevalence (16) 16
protease inhibitors (16) 16
rna, viral - blood (16) 16
viral load (16) 16
medicine (15) 15
safety (15) 15
settore med/17 - malattie infettive (15) 15
antiviral agents - therapeutic use (14) 14
human immunodeficiency virus (14) 14
infections (14) 14
tenofovir (14) 14
anti-hiv agents - adverse effects (13) 13
cohort studies (13) 13
dosage and administration (13) 13
hiv protease inhibitors - therapeutic use (13) 13
prospective studies (13) 13
ritonavir - therapeutic use (13) 13
adults (12) 12
antiretroviral agents (12) 12
clinical trials (12) 12
double-blind (12) 12
efficacy (12) 12
hepatitis c, chronic - drug therapy (12) 12
hiv-1 - physiology (12) 12
hospitals (12) 12
medicine, general & internal (12) 12
multidisciplinary sciences (12) 12
open-label (12) 12
retrospective studies (12) 12
virus diseases (12) 12
adolescent (11) 11
cohort (11) 11
hepatitis (11) 11
hiv infections - epidemiology (11) 11
hiv-infected patients (11) 11
ribonucleic acid--rna (11) 11
rna (11) 11
science (11) 11
settore med/07 - microbiologia e microbiologia clinica (11) 11
viral load - drug effects (11) 11
acquired immune deficiency syndrome (10) 10
antiretrovirals (10) 10
hepacivirus - genetics (10) 10
hiv patients (10) 10
resistance (10) 10
usage (10) 10
abridged index medicus (9) 9
drug administration schedule (9) 9
drug interactions (9) 9
hepatitis c virus (9) 9
hiv-1 (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 21, pp. 1983 - 1992
Journal Article
Journal Article
Expert opinion on pharmacotherapy, 01/2019, p. 1
Despite the potency of current antiretrovirals, some patients continue to struggle with the management of the treatment of HIV due to drug... 
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2013, Volume 208, Issue 1, pp. 32 - 39
Background. Cobicistat (COBI) is a pharmacoenhancer with no antiretroviral activity in vitro. Methods. An international, randomized, double-blind,... 
T lymphocytes | HIV/AIDS | Antiretrovirals | Infectious diseases | RNA | HIV | Drug evaluation | AIDS | Photographs | HIV 1 | Virology | cobicistat | pharmacoenhancer | INFECTIOUS DISEASES | CO-FORMULATED ELVITEGRAVIR | RENAL-FUNCTION | INITIAL TREATMENT | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | DAILY LOPINAVIR/RITONAVIR | GLOMERULAR-FILTRATION-RATE | EFAVIRENZ | DOUBLE-BLIND | ONCE-DAILY DARUNAVIR/RITONAVIR | TENOFOVIR | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Thiazoles - therapeutic use | Oligopeptides - therapeutic use | Anti-HIV Agents - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Pyridines - therapeutic use | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Organophosphonates - therapeutic use | Ritonavir - administration & dosage | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Treatment Outcome | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Adenine - administration & dosage | Organophosphonates - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Carbamates - therapeutic use | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Research | Drug therapy | HIV infection | Patient outcomes
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2010, Volume 51, Issue 8, pp. 963 - 972
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 04/2019, Volume 20, Issue 6, pp. 667 - 678
Introduction: Despite the potency of current antiretrovirals, some patients continue to struggle with the management of the treatment of HIV due to drug... 
antiretroviral | HIV | strategic | adherence | resistance | interactions | EFFICACY | SAFETY | ANTIRETROVIRAL THERAPY | DARUNAVIR/RITONAVIR | DISCONTINUATION | DUAL THERAPY | PHARMACOKINETICS | SALVAGE THERAPY | PHARMACOLOGY & PHARMACY | PLUS RITONAVIR | ETRAVIRINE | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, pp. e0164753 - e0164753
Introduction Little information is available on the efficacy and safety of the dual combination of ripivirine plus dolutegravir. This work aims at beginning to... 
MULTIDISCIPLINARY SCIENCES | Headache - etiology | Follow-Up Studies | Humans | Middle Aged | Drug Resistance, Viral | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - adverse effects | Rilpivirine - therapeutic use | Drug Interactions | HIV-1 - isolation & purification | Rilpivirine - adverse effects | Adult | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Sleep Initiation and Maintenance Disorders - etiology | Drug Administration Schedule | HIV Infections - virology | HIV-1 - genetics | Antiretroviral Therapy, Highly Active | HIV Integrase Inhibitors - adverse effects | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Integrase Inhibitors - therapeutic use | Creatinine - blood | HIV Infections - drug therapy | Aged | Cohort Studies | Virus diseases | DNA polymerases | RNA | Proteases | Headache | Drug abuse | RNA-directed DNA polymerase | Toxicity | Viremia | Clinical trials | Viruses | Ethics | Sleep disorders | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Drug interaction | Drug therapy | Creatinine | Antiretroviral drugs | Level (quantity) | Life expectancy | Drug interactions | Metabolism | Ribonucleic acid--RNA | Infectious diseases | Insomnia | Collaboration | Clinical medicine | Mutation | Females | Index Medicus | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 02/2018, Volume 32, Issue 4, pp. 532 - 533
Journal Article
Journal Article